Establishment Labs Holdings (ESTA) Gross Margin (2017 - 2026)
Establishment Labs Holdings (ESTA) posted Gross Margin of 70.64% for Q2 2026, little changed on a QoQ basis from 70.7% in Q1 2026, and up 188.0% year-over-year from 24.53% in Q2 2025.
Analysis
Establishment Labs Holdings (ESTA) Gross Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings has reported Gross Margin for 10 years, with the latest figure at 70.64% in Q2 2026.
- On a quarterly basis, Gross Margin rose 188.0% year-over-year to 70.64% in Q2 2026; TTM through Jun 2026 was 70.49%, a 325.0% increase from a year earlier, with the FY2025 full-year figure at 69.32%, up 335.0% from the prior year.
- Gross Margin was 70.64% for Q2 2026 at Establishment Labs Holdings, roughly flat from 70.7% in the prior quarter.
- The five-year high for Gross Margin was 70.7% in Q1 2026, with the low at 62.32% in Q2 2023.
- Average Gross Margin over 5 years is 66.96%, with a median of 66.93% recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Gross Margin sank 434 bps in 2023, then surged 616 bps in 2025.
- Over 5 years, Gross Margin stood at 64.28% in 2022, then advanced by 1 bps to 65.22% in 2023, then increased by 5 bps to 68.5% in 2024, then increased by 3 bps to 70.46% in 2025, then climbed by 0 bps to 70.64% in 2026.
- The last three Gross Margin figures came in at 70.64% (Q2 2026), 70.7% (Q1 2026), and 70.46% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | 70.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.64% |
| Mar 31, 2026 | 70.70% |
| Dec 31, 2025 | 70.46% |
| Sep 30, 2025 | 70.09% |
| Jun 30, 2025 | 68.76% |
| Mar 31, 2025 | 67.21% |
| Dec 31, 2024 | 68.50% |
| Sep 30, 2024 | 63.93% |
| Jun 30, 2024 | 65.59% |
| Mar 31, 2024 | 65.60% |
| Dec 31, 2023 | 65.22% |
| Sep 30, 2023 | 67.66% |
| Jun 30, 2023 | 62.32% |
| Mar 31, 2023 | 64.65% |
| Dec 31, 2022 | 64.28% |
| Sep 30, 2022 | 68.09% |
| Jun 30, 2022 | 66.65% |
| Mar 31, 2022 | 64.85% |
| Dec 31, 2021 | 68.60% |
| Sep 30, 2021 | 67.56% |